Ars Pharmaceuticals, Inc.
Clinical trials sponsored by Ars Pharmaceuticals, Inc., explained in plain language.
-
Asthma rescue without needles: nasal spray could replace shots
Disease control CompletedThis phase 2 trial tests a needle-free epinephrine nasal spray (ARS-1) for managing asthma symptoms. People with persistent asthma receive a single dose of ARS-1, albuterol, or placebo in random order. The study measures how well the spray improves lung function compared to stand…
Phase: PHASE2 • Sponsor: ARS Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Nasal spray may offer fast hives relief without needles
Symptom relief CompletedThis study tested a single dose of a nasal spray called ARS-1 (intranasal epinephrine) in 21 adults who get frequent hives and itching. The goal was to see if the spray works faster and better than a placebo at reducing itch and hive scores during flare-ups. Participants were mon…
Phase: PHASE2 • Sponsor: ARS Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC